UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission file number: 001-40949 ENFUSION, INC. (Exact name of registrant as specified in its charter) Delaware 87-1268462 (State of Other Jurisdiction of incorporation o ...

Enfusion, Inc. (NYSE:ENFN) Q4 2022 Results Conference Call March 7, 2023 8:30 AM ET Company Participants Ignatius Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants James Faucette - Morgan Stanley Kevin McVeigh - Credit Suisse Dylan Becker - William Blair Koji Ikeda - Bank of America Matthew Kikkert - Stifel Operator Good morning, ladies and gentlemen and thank you for standing by. Welcome to Enfusion's Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] A ...